BOL-303224

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOL-303224, covering 2009-08-13 to 2009-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis [Phase 3]

See pricing